Though not without a bump along the way, Roivant-backed Priovant Therapeutics has pushed its dual TYK2/JAK1 inhibitor across ...

The FDA approval of Bixlenvo tees up a new HIV treatment option for virologically suppressed adults, including those on ...

RevMed’s leadership, too, highlighted the significance of Rasonque’s approval in a call with investors yesterday.

On Wednesday, the U.S. Court of Appeals for the Fifth Circuit affirmed (PDF) a previous ruling in district court rebuffing ...

Artis BioSolutions opened the doors to a new manufacturing center in Bilbao, Spain, that expands the CDMO’s production ...

Amgen and AstraZeneca’s inflammatory disease drug Tezspire has clinched a phase 3 win in eosinophilic esophagitis (EoE) as ...

Bristol Myers Squibb, by way of its RayzeBio unit, has taken a big step in furthering its commitment to radiopharmaceuticals, ...

The Trump administration looks set to unveil a new slate of most favored nation (MFN) drug pricing deals with several ...

By Alicia Cowley, MD, MBA, Medical Director, Phreesia Network Solutions | Endemic media and broad reach each do half the job.

Frontier Large Language Models have improved. More data became accessible. Neither solved the hardest questions. Here's what ...

Less than a month after initiating a drug recall after cardboard was fou | Baxter has initiated a recall of two products ...

Fresh off a phase 3 win in biliary tract cancer, Akeso CEO Michelle Xia, Ph.D., is touting the PD-1xVEGF bispecific antibody ...